Thursday, October 22, 2020

Design Therapeutics Appoints Industry Veteran, Dr. João Siffert, as Chief Executive Officer

›
Design Therapeutics. San Diego, Calif., Oct. 20, 2020 Design Therapeutics, a biotechnology company developing a platform of gene targeted ch...
Monday, October 19, 2020

Assessment of Ataxia Rating Scales and Cerebellar Functional Tests: Critique and Recommendations

›
Perez-Lloret S, van de Warrenburg B, Rossi M, Rodríguez-Blázquez C, Zesiewicz T, Saute JAM, Durr A, Nishizawa M, Martinez-Martin P, Stebbins...
Sunday, October 18, 2020

Safety and Efficacy of Omaveloxolone in Friedreich's Ataxia (MOXIe Study)

›
Lynch, D.R., Chin, M.P., Delatycki, M.B., Subramony, S., Corti, M., Hoyle, J.C., Boesch, S., Nachbauer, W., Mariotti, C., Mathews, K.D., Giu...
Saturday, October 17, 2020

Reata Pharma Accused in Securities Suit of Hyping Drug Prospects

›
PHILADELPHIA, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of ...
Friday, October 16, 2020

Longitudinal Study of Cognitive Functioning in Friedreich’s Ataxia

›
Atteneri Hernández-Torres, Fernando Montón, Stephany Hess Medler, Érika de Nóbrega and Antonieta Nieto; Longitudinal Study of Cognitive Func...
Thursday, October 15, 2020

Larimar Therapeutics Announces Formation of Scientific Advisory Board

›
BALA CYNWYD, Pa., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Nasdaq:LRMR), a clinical-stage biotechnology company focused...
Wednesday, October 14, 2020

Inhibition of the SUV4-20 H1 histone methyltransferase increases frataxin expression in Friedreich's ataxia patient cells

›
Vilema-Enríquez G, Quinlan R, Kilfeather P, Mazzone R, Saqlain S, Del Molino Del Barrio I, Donato A, Corda G, Li F, Vedadi M, Németh AH, Bre...
Tuesday, October 13, 2020

Sexual function, intimate relationships and Friedreich ataxia

›
Louise A. Corben, Mireille M. Hermans, Alice Marks, Louise M. Crowe & Martin B. Delatycki; J Neurol (2020). https://doi.org/10.1007/s004...
Monday, October 12, 2020

Sensitivity of Neuroimaging Indicators in Monitoring the Effects of Interferon Gamma Treatment in Friedreich’s Ataxia

›
Marinela Vavla, Filippo Arrigoni, Nicola Toschi, Denis Peruzzo, Maria Grazia D’Angelo, Sandra Gandossini, Annamaria Russo, Eleonora Diella, ...
Sunday, October 11, 2020

A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia

›
ClinicalTrials.gov Identifier: NCT04577352 Randomized, Parallel-Arm, Double-Blind, Placebo-Controlled Study With Open-Label Extension to Ass...